The Patent Finder

Merrimack Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Merrimack Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Back to Merrimack Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,329,213Liposomes Useful for Drug Delivery
In force
 · High confidence
In forceHigh confidence
US 7,846,440Antibodies Against ERBB3 and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 9,487,588Antibodies Against the Ectodomain of ERBB3 and Uses Thereof
In force
 · Low confidence
In forceLow confidence
US 8,147,867Liposomes Useful for Drug Delivery
In force
 · High confidence
In forceHigh confidence
US 8,691,225Antibodies Against the Ectodomain of ERBB3 and Uses Thereof
In force
 · Medium confidence
In forceMedium confidence
US 8,658,203Liposomes Useful for Drug Delivery to the Brain
In force
 · High confidence
In forceHigh confidence
US 8,961,966Antibodies Against ERBB3 and Uses Thereof
In force
 · Low confidence
In forceLow confidence
US 9,238,080Bi-specific fusion proteins
In force
 · Medium confidence
In forceMedium confidence
US 9,718,892A method of treating myocardial infarction by administering a bi-specific fusion protein
In force
 · High confidence
In forceHigh confidence
US 9,982,060Bi-Specific Fusion Proteins
In force
 · High confidence
In forceHigh confidence
10 of 198 records shown.
Pro members see all 198.
Pro members: see all 198 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited